Filter by Last updated date SelectAfterBeforeFrom - To Date End Date This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorSpeechParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Results (3876) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Public Statement on Ziagen (Abacavir) - Abacavir hypersensitivity cases following an interruption of therapy 14 August 2000News Committee for Proprietary Medicinal Products (CPMP) 62nd plenary meeting 31 July 2000Press release Changes in the Human Medicines Evaluation Unit and nomination of new Head of Unit 25 July 2000Press releaseHumanMedicines Committee for veterinary medicinal products: 57th meeting 20 July 2000Press releaseVeterinary 4th meeting of the Committee for Orphan Medicinal Products 14 July 2000Press releaseHumanRare diseases Committee for Proprietary Medicinal Products (CPMP) 61st plenary meeting 4 July 2000Press release Personal Message from Mr Fernand Sauer, EMEA Executive Director (29 June 2000) 29 June 2000Press release Committee for veterinary medicinal products: 56th meeting 22 June 2000Press releaseVeterinary Twenty-sixth meeting of the Management Board 9 June 2000Press releaseCorporate Tripartite Meeting (JPMA/PhRMA/EBC-PC) hosted by EMEA: 'Approving Innovative Medicines in 21st Century' 30 May 2000Press releaseMedicines 1 … 368 369 370 371 372 Page 372 of 388 373 374 375 376 … 388
Public Statement on Ziagen (Abacavir) - Abacavir hypersensitivity cases following an interruption of therapy 14 August 2000News
Changes in the Human Medicines Evaluation Unit and nomination of new Head of Unit 25 July 2000Press releaseHumanMedicines
4th meeting of the Committee for Orphan Medicinal Products 14 July 2000Press releaseHumanRare diseases
Personal Message from Mr Fernand Sauer, EMEA Executive Director (29 June 2000) 29 June 2000Press release
Tripartite Meeting (JPMA/PhRMA/EBC-PC) hosted by EMEA: 'Approving Innovative Medicines in 21st Century' 30 May 2000Press releaseMedicines